| Acute Coronary Syndrome |
1 |
0.9 |
| Percutaneous Coronary Intervention |
0 |
0.9 |
| Stent |
0 |
0.56 |
| Hemorrhage |
0 |
0.51 |
| Coronary Stent |
0 |
0.44 |
| Thromboembolism |
0 |
0.43 |
| Cerebrovascular Accident |
0 |
0.24 |
| Hospital |
0 |
0.23 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.18 |
| HIV Infection |
0 |
0.18 |
| Myocardial Infarction (MI) |
0 |
0.18 |
| Anticoagulation Therapy |
0 |
0.17 |
| Grant |
0 |
0.17 |
| Infarction |
0 |
0.11 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.11 |
| Antithrombotics |
0 |
0.06 |
| Aspirin |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Europe |
0 |
0.06 |
| New York |
0 |
0.06 |
| Thrombosis |
0 |
0.06 |
| Transplant Evaluation |
0 |
0.06 |